++
Section III. Occupational Illnesses
++
++
++
++
++
++
a. are engineered structures that are less than 100 nm in size
++
++
b. have no chemical properties
++
++
c. are blocked from the central nervous system
++
++
d. are easily measured in biologic tissues
+
++
a. Nanoparticles are engineered structures that are less than 100 nm in size.
++
++
++
++
++
++
a. affects all ages to the same degree
++
++
b. is independent of racial and genetic background
++
++
c. has no important genetic factors
++
++
d. is affected by atmospheric pressure, temperature, and humidity
+
++
d. Toxicity is affected by atmospheric pressure, temperature, and humidity.
++
++
++
++
++
++
a. primarily affects white males and persons of Mediterranean descent
++
++
b. is an X-linked recessive disorder
++
++
c. prevents hemolysis from many drugs
++
++
d. screening is supported by solid evidence
+
++
b. G6PD deficiency is an X-linked recessive disorder.
++
++
++
++
++
++
a. occurs in the liver by hydrolysis, oxidation, reduction, and conjugation
++
++
b. is independent of microsomal cytochrome P450
++
++
c. can be arrested by many environmental and pharmacologic agents
++
++
d. is accelerated in neonates
+
++
a. Biotransformation occurs in the liver by hydrolysis, oxidation, reduction, and conjugation.
++
++
++
++
++
++
a. is the rate at which a toxic agent is excreted, multiplied by the average concentration of the agent in the plasma
++
++
b. is a function of concentration in the urine, unrelated to dose
++
++
c. is a measure of how many milligrams of toxin is being removed
++
++
d. is a measure of the volume of fluid that is freed of the toxic agent per unit of time
+
++
d. Clearance is a measure not of how many milligrams of toxin is being removed but rather of the volume of fluid that is freed of the toxic agent per unit of time.
++
++
++
++...